Valuation : Grifols, S.A.

Market Cap 5.87B 6.82B 5.52B 5.04B 9.46B 649B 9.53B 65.37B 25.43B 329B 25.62B 25.06B 1,090B P/E 2026 *
12.5x
P/E 2027 * 9.58x
Enterprise Value 14.32B 16.63B 13.45B 12.27B 23.06B 1,583B 23.22B 159B 61.99B 802B 62.45B 61.09B 2,657B EV / Sales 2026 *
1.87x
EV / Sales 2027 * 1.72x
Free-Float
79.65%
Yield 2026 *
2.8%
Yield 2027 * 3.06%
1 day-0.18%
1 week-0.87%
Current month-1.71%
1 month-1.71%
3 months+6.36%
6 months-1.78%
Current year-8.47%
1 week 9.76
Extreme 9.76
10.17
1 month 9.62
Extreme 9.622
10.32
Current year 8.43
Extreme 8.432
11.7
1 year 8.43
Extreme 8.432
12.87
3 years 6.36
Extreme 6.362
15.92
5 years 6.36
Extreme 6.362
22.64
10 years 6.36
Extreme 6.362
34.31
Manager TitleAgeSince
Chief Executive Officer 58 2024-03-31
Director of Finance/CFO 49 2024-09-15
Compliance Officer 54 2013-12-31
Director TitleAgeSince
Chairman 76 2010-01-24
Director/Board Member 70 2000-04-12
Director/Board Member 62 2015-05-23
Date Insider Type Main position Quantity % Market Cap. Importance
2/26/26 Free

Director

7,679 0.0018%
2/26/26 Free

Director

1,408 0.0005%
2/18/26 Others

Director

1,408 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
-0.20%-0.87%-19.46%-22.55% 6.82B
+0.62%-3.55%+38.27%-3.32% 79.79B
+0.43%+1.89%-18.05%-37.01% 58.85B
+1.70%+1.04%+480.16%+24.12% 56.03B
+2.15%-2.13%-1.37%+30.77% 51.26B
+1.86%-0.32%+10.09%+164.86% 47.68B
-0.85%-0.67%+55.16%-18.97% 32.01B
-0.92%-3.72%+43.31%+90.95% 24.98B
-2.12%+2.11%-3.61%+189.46% 23.05B
+1.58%+0.84%+61.06%+115.41% 16.31B
Average +0.05%-0.87%+64.56%+53.37% 39.68B
Weighted average by Cap. +0.21%-1.40%+83.00%+40.59%

Financials

2026 *2027 *
Net sales 7.66B 8.89B 7.19B 6.56B 12.33B 846B 12.42B 85.18B 33.14B 429B 33.38B 32.66B 1,420B 8.13B 9.45B 7.64B 6.97B 13.1B 899B 13.19B 90.51B 35.21B 456B 35.47B 34.7B 1,509B
Net income 536M 622M 503M 459M 862M 59.19B 869M 5.96B 2.32B 30.01B 2.34B 2.28B 99.38B 699M 812M 657M 599M 1.13B 77.28B 1.13B 7.78B 3.03B 39.19B 3.05B 2.98B 130B
Net Debt 8.45B 9.81B 7.93B 7.24B 13.6B 933B 13.7B 93.96B 36.56B 473B 36.83B 36.03B 1,567B 8.1B 9.41B 7.61B 6.95B 13.05B 896B 13.14B 90.17B 35.08B 454B 35.34B 34.57B 1,504B
Logo Grifols, S.A.
Grifols, S.A. specializes in the research, development, manufacturing and marketing of therapeutic products and medical devices for use in hospitals and medical analysis laboratories. Net sales break down by family of products and services as follows: - products derived from plasma (86.2%): products for use by the pharmaceutical and biotechnology industries; - diagnostic machines and reagents (8.5%): in vitro hemophilic diagnostic equipment, coagulation analyzers, infectious serology reagents, etc. for use primarily by blood banks and transfusion centers; - hospital products (2.1%): non-biological surgical products, radiology and nutritional products, etc. for use by hospital pharmacies; - other (3.2%): primarily intermediate biological products and subcontracted manufacturing services. Net sales are distributed geographically as follows: Spain (5.6%), European Union (15.9%), the United States and Canada (56.5%) and other (22%).
Employees
25,258
Date Price Change Volume
26-09-01 9.800 -0.33% 361,879
26-08-31 €9.832 -1.19% 962,512
26-08-28 €9.950 -1.04% 979,824
26-08-27 €10.06 +0.20% 764,067
26-08-26 €10.04 -0.10% 951,980
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
9.832EUR
Average target price
14.76EUR
Spread / Average Target
+50.11%

Quarterly revenue - Rate of surprise